Chen Mingxiong, Jiang Yilin, Yu Hanrui, Qi Haolan, Li Xiaoqi, Wang Junyi, Wang An, Li Zhao, Wang Qun, Huang Yifei, Wang Liqiang
Senior Department of Ophthalmology, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
National Key Laboratory of Kidney Diseases, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Invest Ophthalmol Vis Sci. 2025 Sep 2;66(12):58. doi: 10.1167/iovs.66.12.58.
We aimed to investigate whether hydrogen sulfide (H2S)-preconditioned mesenchymal stem cells (MSCs) could enhance the anti-ferroptotic effects in a murine model of corneal alkali burn.
MSCs were treated with various concentrations of GYY4137 (an H2S donor) and Western blot was used to detect the expression of IL-10 and cleaved-caspase-3. Slit-lamp photography and hematoxylin and eosin (H&E) staining were used to observe corneal structure after receiving a single subconjunctival injection of H2S-MSCs. Quantitative PCR (QPCR) or Western blot were used to detect the expression of pro-inflammatory cytokines, ferroptosis-regulatory molecules (SLC7A11, GPX4, 4-HNE, and FTH1) and AMPK/Nrf2/HO-1 pathway on day 7 after corneal injury. A co-culture model of human corneal epithelial cells (HCECs) and MSCs was used to investigate the anti-ferroptotic effects of MSCs.
Under the stimulation of 1 µmol/L GYY4137 for 48 hours, MSCs showed enhanced expression of IL-10. Furthermore, H2S pretreatment suppressed hydrogen peroxide (H2O2)- or serum deprivation-induced MSC apoptosis in vitro. On days 7 and 14 post-treatment, corneal opacity was ameliorated and corneal structure was more regular in the H2S-MSC group. H2S-MSC effectively attenuated ferroptosis in the cornea and HCECs by upregulating the expression of SLC7A11 and GPX4, while suppressing the level of 4-HNE and FTH1. Meanwhile, H2S-MSC activated AMPK/Nrf2/HO-1 pathway in vitro and in vivo. Knockdown of IL-10 via siRNA attenuated the inhibitory effects of H2S-MSC on erastin-induced ferroptosis in HCECs.
H2S preconditioning augmented the anti-inflammatory and anti-ferroptotic effects of MSCs via activation of the AMPK/Nrf2/HO-1 pathway in an IL-10-dependent way, offering a novel strategy for corneal alkali burn treatment.